Vikas Sinha, Director at Verona Pharma plc (VRNA), sold 320,000 shares at $8.92 ($2.9M) on 2025-04-29, disclosed to the SEC on 2025-05-22.
Scheduled sale ($2.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.92 | 39,616 | $353K | 12.4% |
| 2 | $8.92 | 39,616 | $353K | 12.4% |
| 3 | $8.92 | 120,384 | $1.1M | 37.6% |
| 4 | $8.92 | 120,384 | $1.1M | 37.6% |
| Total | $8.92 avg | 320,000 | $2.9M | 100% |
| Filing → |
| VRNA | SELL | 2025-08-05 | $114K | — | Filing → |
| VRNA | SELL | 2025-05-22 | $1.5M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $178K | — | Filing → |